Relievus Pain Management offers patients ketamine therapy for their chronic pain and mood disorders. Specific conditions they treat include complex regional pain syndrome, reflex sympathetic dystrophy, and major depression. Ketamine therapy has been shown to be effective in up to 70 percent of patients, and that is why the medical team at the health center offers it.
Ready to explore a new horizon in mental health? Try out the beta version of HealingChat, HealingMaps AI chatbot that takes all our vetted content, clinics and retreats to answer all your questions in a safe environment. Try the beta version now!
Many people suffer from treatment-resistant disorders, which can significantly decrease their quality of life. The medical professionals at Relievus Pain Management understand how frustrating that can be. That is why they are dedicated to providing the best care and latest treatment options available to them. By using ketamine therapy, they can help more people regain control of their lives.
Offered Treatments
IV Ketamine Infusion Therapy
Treated Conditions
CRPS (Complex Regional Pain Syndrome) or RSD (Reflex Sympathetic Dystrophy)
Major Depression
Important Info
Patients do not need a referral; however, they will need to provide documentation from their primary care, pain specialist, psychiatrist, or therapist related to their diagnosis and past treatment. Patients will be required to continue regular ongoing contact with them during and after ketamine infusions.
Relievus Pain Management’s ketamine treatments have no formal age limitations.
Those with uncontrolled blood pressure, unstable heart disease, untreated thyroid disease, active substance abuse, along with anyone currently in the manic phase of bipolar disorder or experiencing active psychotic symptoms (hallucinations or delusions), might not be eligible for ketamine therapy at Relievus Pain Management.
Ketamine infusion costs vary (see Relievus Pain Management’s pricing below), and since insurance providers rarely cover these treatments, it’s best to check with your carrier beforehand.
Your Treatment: What to Expect at Relievus Pain Management
A preliminary consultation and evaluation of your medical history will determine if you’re a worthwhile candidate for ketamine and assess if you have any health conditions that make ketamine unsafe. If you’re approved to proceed with ketamine infusion therapy, Relievus Pain Management typically begins with one or two infusions back to back to see if they are effective for you.
During the infusions, ketamine is administered over a period of 45 minutes to 60 minutes. The amount given will not cause you to lose consciousness. During the infusion, most patients have a mild dissociative experience, with increased sensitivity to light and sound and an altered perception of time and color. Most patients tolerate these experiences without discomfort and many people find them to be pleasant. In the rare case these side effects are considered unpleasant, other rapid-acting medications can be used to relieve or eliminate this discomfort. Once the infusion is complete, the dissociative effects of the drug rapidly dissipate and are often mostly gone within 20-30 minutes. There are no delayed “flashbacks” and patients generally leave Relievus Pain Management’s offices within 30 minutes following the infusion and aside from mild fatigue, feel much like themselves.
Most patients who respond to the infusions see some improvement the day of or after their second infusion. If not, Relievus Pain Management may attempt a longer and/or higher dose infusion. If there is still no response, the clinic generally stops further treatment. If ketamine does improve your mood, outlook, and functionality, Relievus Pain Management suggests that you receive 2-4 additional infusions over the next 4 weeks (1-2 infusions every 2 weeks) to maximize ketamine’s brain-repairing abilities. That is a total of 6 infusions for one full series.
The Healing Maps Editorial Team has decades of experience across all facets of the psychedelic industry. From assessing studies and clinic research, to working with clinician's and clinics, we help provide data-backed information to psychedelic-curious individuals across the globe.
Michael Turner
December 20, 2023 at 12:23 pmas you can see this hasn’t had a reply since April
Helpful Review 1Julie Wilson
April 10, 2023 at 3:32 pmHello.
Helpful Review 1I have had fibro since .2012, Do you know if nj horizon covers the iv fr ketamine? If not how much is it?